Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus

被引：0
作者：
Steven Vernino
Daniel Claassen
机构：
[1] UT Southwestern,Department of Neurology and Neurotherapeutics
[2] University of Southern California,Department of Neurology
来源：
Clinical Autonomic Research | 2017年 / 27卷
关键词：
Type 2 diabetes mellitus; Parkinson disease; Neurogenic orthostatic hypotension; Droxidopa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：33 / 34
页数：1
相关论文
共 44 条
  • [41] Type 2 diabetes mellitus as a determinant factor for the age of Parkinson?s disease onset
    Cervantes-Arriaga, Amin
    Esquivel-Zapata, Oscar
    Escobar-Valdivia, Emmanuel
    Garcia-Romero, David
    Munuzuri-Camacho, Marco
    Hernandez-Medrano, Ana J.
    Abundes-Corona, Arturo
    Rodriguez-Violante, Mayela
    REVISTA MEXICANA DE NEUROCIENCIA, 2023, 24 (01): : 3 - 7
  • [42] ANAESTHETIC MANAGEMENT OF A GERIATRIC PATIENT WITH PARKINSON'S DISEASE AND DIABETES MELLITUS POSTED FOR EMERGENCY LAPAROTOMY
    Patel, Prajwal H. S.
    Shivaramu, B. T.
    Metri, Vidyadhar
    Amith, S.
    Kumar, Kislaya
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (51): : 12048 - 12052
  • [43] NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
    Alrouji, Mohammed
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Alexiou, Athanasios
    Papadakis, Marios
    Jabir, Majid S.
    Saad, Hebatallah M.
    Batiha, Gaber El-Saber
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (13) : 1775 - 1789
  • [44] Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes
    Guo, Jingchuan
    Tang, Huilin
    Shao, Hui
    Lu, Ying
    Shi, Lizheng
    Fonseca, Vivian A.
    Cho, Hwayoung
    Guo, Yi
    Bian, Jiang
    DIABETES OBESITY & METABOLISM, 2024, 26 (12) : 5727 - 5736
12345